{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T18:16:21Z","timestamp":1785262581077,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T00:00:00Z","timestamp":1525392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00277-018-3346-1","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T02:30:02Z","timestamp":1525401002000},"page":"1633-1640","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Incidence, predictive factors, management, and survival impact of atrial fibrillation in non-Hodgkin lymphoma"],"prefix":"10.1007","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0587-591X","authenticated-orcid":false,"given":"Marc","family":"Sorigue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Gual-Capllonch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edurne","family":"Sarrate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Franch-Sarto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladys","family":"Ibarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Orna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep-Maria","family":"Ribera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Manuel","family":"Sancho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,4]]},"reference":[{"key":"3346_CR1","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","volume":"285","author":"AS Go","year":"2001","unstructured":"Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA 285:2370\u20132375","journal-title":"JAMA"},{"key":"3346_CR2","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jacc.2013.11.026","volume":"63","author":"D Farmakis","year":"2014","unstructured":"Farmakis D, Parissis J, Filippatos G (2014) Insights into onco-cardiology: atrial fibrillation in cancer. J Am Coll Cardiol 63:945\u2013953. https:\/\/doi.org\/10.1016\/j.jacc.2013.11.026","journal-title":"J Am Coll Cardiol"},{"key":"3346_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.thromres.2017.05.006","volume":"155","author":"T Fitzpatrick","year":"2017","unstructured":"Fitzpatrick T, Carrier M, Le Gal G (2017) Cancer, atrial fibrillation, and stroke. Thromb Res 155:101\u2013105. https:\/\/doi.org\/10.1016\/j.thromres.2017.05.006","journal-title":"Thromb Res"},{"key":"3346_CR4","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","volume":"100","author":"P Prandoni","year":"2002","unstructured":"Prandoni P, Lensing AW, Piccioli A, Bernardi E, Simioni P, Girolami B, Marchiori A, Sabbion P, Prins MH, Noventa F, Girolami A (2002) Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 100:3484\u20133488. https:\/\/doi.org\/10.1182\/blood-2002-01-0108","journal-title":"Blood"},{"key":"3346_CR5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1160\/TH08-02-0125","volume":"100","author":"J Trujillo-Santos","year":"2008","unstructured":"Trujillo-Santos J, Nieto JA, Tiberio G, Piccioli A, Di Micco P, Prandoni P, Monreal M, Registry RIETE (2008) Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE registry. Thromb Haemost 100:435\u2013439","journal-title":"Thromb Haemost"},{"key":"3346_CR6","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","volume":"111","author":"AA Khorana","year":"2008","unstructured":"Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW (2008) Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111:4902\u20134907. https:\/\/doi.org\/10.1182\/blood-2007-10-116327","journal-title":"Blood"},{"key":"3346_CR7","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1080\/10428194.2016.1257795","volume":"58","author":"TD Shanafelt","year":"2017","unstructured":"Shanafelt TD, Parikh SA, Noseworthy PA, Goede V, Chaffee KG, Bahlo J, Call TG, Schwager SM, Ding W, Eichhorst B, Fischer K, Leis JF, Chanan-Khan AA, Hallek M, Slager SL, Kay NE (2017) Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL). Leuk Lymphoma 58:1630\u20131639. https:\/\/doi.org\/10.1080\/10428194.2016.1257795","journal-title":"Leuk Lymphoma"},{"key":"3346_CR8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373\u2013383","journal-title":"J Chronic Dis"},{"key":"3346_CR9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0025-6196(11)60754-4","volume":"84","author":"MA Crandall","year":"2009","unstructured":"Crandall MA, Bradley DJ, Packer DL, Asirvatham SJ (2009) Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies. Mayo Clin Proc 84:643\u2013662. https:\/\/doi.org\/10.1016\/S0025-6196(11)60754-4","journal-title":"Mayo Clin Proc"},{"key":"3346_CR10","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C (2005) Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3:692\u2013694. https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01204.x","journal-title":"J Thromb Haemost"},{"key":"3346_CR11","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1157\/13107118","volume":"60","author":"L Cea-Calvo","year":"2007","unstructured":"Cea-Calvo L, Red\u00f3n J, Lozano JV, Fern\u00e1ndez-P\u00e9rez C, Mart\u00ed-Canales JC, Llisterri JL, Gonz\u00e1lez-Esteban J, Aznar J, Investigators of the PREV-ICTUS Study (2007) Prevalence of atrial fibrillation in the Spanish population aged 60 years or more. The PREV-ICTUS study. Rev Esp Cardiol 60:616\u2013624","journal-title":"Rev Esp Cardiol"},{"key":"3346_CR12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.recesp.2013.07.015","volume":"67","author":"JJ G\u00f3mez-Doblas","year":"2014","unstructured":"G\u00f3mez-Doblas JJ, Mu\u00f1iz J, Martin JJ, Rodr\u00edguez-Roca G, Lobos JM, Awamleh P, Permanyer-Miralda G, Chorro FJ, Anguita M, Roig E, OFRECE study collaborators (2014) Prevalence of atrial fibrillation in Spain. OFRECE study results. Rev Esp Cardiol (Engl Ed) 67:259\u2013269. https:\/\/doi.org\/10.1016\/j.rec.2013.07.014","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"3346_CR13","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1161\/CIRCULATIONAHA.116.023163","volume":"136","author":"DH Lau","year":"2017","unstructured":"Lau DH, Nattel S, Kalman JM, Sanders P (2017) Modifiable risk factors and atrial fibrillation. Circulation 136:583\u2013596. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.023163","journal-title":"Circulation"},{"key":"3346_CR14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ijcard.2012.08.036","volume":"165","author":"YF Hu","year":"2013","unstructured":"Hu YF, Liu CJ, Chang PM, Tsao HM, Lin YJ, Chang SL, Lo LW, Tuan TC, Li CH, Chao TF, Chung FP, Liao JN, Chen TJ, Chen SA (2013) Incident thromboembolism and heart failure associated with new-onset atrial fibrillation in cancer patients. Int J Cardiol 165:355\u2013357. https:\/\/doi.org\/10.1016\/j.ijcard.2012.08.036","journal-title":"Int J Cardiol"},{"key":"3346_CR15","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","volume":"146","author":"RG Hart","year":"2007","unstructured":"Hart RG, Pearce LA, Aguilar MI (2007) Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146:857\u2013867","journal-title":"Ann Intern Med"},{"key":"3346_CR16","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.amjmed.2009.11.025","volume":"123","author":"IM Ogilvie","year":"2010","unstructured":"Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY (2010) Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 123:638\u2013645.e4. https:\/\/doi.org\/10.1016\/j.amjmed.2009.11.025","journal-title":"Am J Med"},{"key":"3346_CR17","doi-asserted-by":"publisher","first-page":"e67806","DOI":"10.1371\/journal.pone.0067806","volume":"8","author":"DL Arts","year":"2013","unstructured":"Arts DL, Visscher S, Opstelten W, Korevaar JC, Abu-Hanna A, van Weert HC (2013) Frequency and risk factors for under- and over-treatment in stroke prevention for patients with non-valvular atrial fibrillation in general practice. PLoS One 8:e67806. https:\/\/doi.org\/10.1371\/journal.pone.0067806","journal-title":"PLoS One"},{"key":"3346_CR18","doi-asserted-by":"publisher","first-page":"e63479","DOI":"10.1371\/journal.pone.0063479","volume":"8","author":"AK Kakkar","year":"2013","unstructured":"Kakkar AK, Mueller I, Bassand JP, Fitzmaurice DA, Goldhaber SZ, Goto S, Haas S, Hacke W, Lip GY, Mantovani LG, Turpie AG, van Eickels M, Misselwitz F, Rushton-Smith S, Kayani G, Wilkinson P, Verheugt FW, Registry Investigators GARFIELD (2013) Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry. PLoS One 8:e63479. https:\/\/doi.org\/10.1371\/journal.pone.0063479","journal-title":"PLoS One"},{"key":"3346_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.thromres.2016.02.023","volume":"140","author":"N Mochalina","year":"2016","unstructured":"Mochalina N, J\u00f6ud A, Carlsson M, Sandberg MEC, Sj\u00e4lander A, Juhlin T, Svensson PJ (2016) Antithrombotic therapy in patients with non-valvular atrial fibrillation in Southern Sweden: a population-based cohort study. Thromb Res 140:94\u201399. https:\/\/doi.org\/10.1016\/j.thromres.2016.02.023","journal-title":"Thromb Res"},{"key":"3346_CR20","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1093\/europace\/euw295","volume":"18","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P, Agewall S, Camm J, Baron Esquivias G, Budts W, Carerj S, Casselman F, Coca A, De Caterina R, Deftereos S, Dobrev D, Ferro JM, Filippatos G, Fitzsimons D, Gorenek B, Guenoun M, Hohnloser SH, Kolh P, Lip GY, Manolis A, McMurray J, Ponikowski P, Rosenhek R, Ruschitzka F, Savelieva I, Sharma S, Suwalski P, Tamargo JL, Taylor CJ, Van Gelder IC, Voors AA, Windecker S, Zamorano JL, Zeppenfeld K (2016) 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace 18:1609\u20131678. https:\/\/doi.org\/10.1093\/europace\/euw295","journal-title":"Europace"},{"key":"3346_CR21","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.amjmed.2013.12.022","volume":"127","author":"GY Lip","year":"2014","unstructured":"Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Ioachim PM, Tica O, Boriani G, Cimaglia P, Diemberger I, Hellum CF, Mortensen B, Maggioni AP (2014) \u2018Real-world\u2019 antithrombotic treatment in atrial fibrillation: the EORP-AF pilot survey. Am J Med 127:519\u201329.e1. https:\/\/doi.org\/10.1016\/j.amjmed.2013.12.022","journal-title":"Am J Med"},{"key":"3346_CR22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/jth.12845","volume":"13","author":"A Gorst-Rasmussen","year":"2015","unstructured":"Gorst-Rasmussen A, Skj\u00f8th F, Larsen TB, Rasmussen LH, Lip GY, Lane DA (2015) Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study. J Thromb Haemost 13:495\u2013504. https:\/\/doi.org\/10.1111\/jth.12845","journal-title":"J Thromb Haemost"},{"key":"3346_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1160\/TH15-04-0350","volume":"115","author":"C Martinez","year":"2016","unstructured":"Martinez C, Katholing A, Wallenhorst C, Freedman SB (2016) Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study. Thromb Haemost 115:31\u201339. https:\/\/doi.org\/10.1160\/TH15-04-0350","journal-title":"Thromb Haemost"},{"key":"3346_CR24","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ijcard.2015.10.166","volume":"203","author":"YJ Lee","year":"2016","unstructured":"Lee YJ, Park JK, Uhm JS, Kim JY, Pak HN, Lee MH, Sung JH, Joung B (2016) Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy. Int J Cardiol 203:372\u2013378. https:\/\/doi.org\/10.1016\/j.ijcard.2015.10.166","journal-title":"Int J Cardiol"},{"key":"3346_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.thromres.2016.05.028","volume":"144","author":"DB Ambrus","year":"2016","unstructured":"Ambrus DB, Reisman JI, Rose AJ (2016) The impact of new-onset cancer among veterans who are receiving warfarin for atrial fibrillation and venous thromboembolism. Thromb Res 144:21\u201326. https:\/\/doi.org\/10.1016\/j.thromres.2016.05.028","journal-title":"Thromb Res"},{"key":"3346_CR26","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.thromres.2015.06.011","volume":"136","author":"G Denas","year":"2015","unstructured":"Denas G, Pengo V, Joppi R, Prandoni P (2015) Cancer as a risk factor for stroke in atrial fibrillation patients receiving long-term oral anticoagulant therapy. Thromb Res 136:488. https:\/\/doi.org\/10.1016\/j.thromres.2015.06.011","journal-title":"Thromb Res"},{"key":"3346_CR27","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1634\/theoncologist.2013-0239","volume":"19","author":"NJ Short","year":"2014","unstructured":"Short NJ, Connors JM (2014) New oral anticoagulants and the cancer patient. Oncologist 19:82\u201393. https:\/\/doi.org\/10.1634\/theoncologist.2013-0239","journal-title":"Oncologist"},{"key":"3346_CR28","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1378\/chest.14-0402","volume":"147","author":"MC Vedovati","year":"2015","unstructured":"Vedovati MC, Germini F, Agnelli G, Becattini C (2015) Direct oral anticoagulants in patients with VTE and cancer: a systematic review and meta-analysis. Chest 147:475\u2013483. https:\/\/doi.org\/10.1378\/chest.14-0402","journal-title":"Chest"},{"key":"3346_CR29","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1056\/NEJMoa1711948","volume":"378","author":"GE Raskob","year":"2018","unstructured":"Raskob GE, van Es N, Verhamme P, Carrier M, Di Nisio M, Garcia D, Grosso MA, Kakkar AK, Kovacs MJ, Mercuri MF, Meyer G, Segers A, Shi M, Wang TF, Yeo E, Zhang G, Zwicker JI, Weitz JI, B\u00fcller HR, Hokusai VTE Cancer Investigators (2018) Edoxaban for the treatment of cancer-associated venous thromboembolism. N Engl J Med 378:615\u2013624. https:\/\/doi.org\/10.1056\/NEJMoa1711948.","journal-title":"N Engl J Med"},{"key":"3346_CR30","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.amjmed.2017.06.026","volume":"130","author":"C Melloni","year":"2017","unstructured":"Melloni C, Dunning A, Granger CB, Thomas L, Khouri MG, Garcia DA, Hylek EM, Hanna M, Wallentin L, Gersh BJ, Douglas PS, Alexander JH, Lopes RD (2017) Efficacy and safety of apixaban versus warfarin in patients with atrial fibrillation and a history of cancer: insights from the ARISTOTLE trial. Am J Med 130:1440\u20131448. https:\/\/doi.org\/10.1016\/j.amjmed.2017.06.026","journal-title":"Am J Med"},{"key":"3346_CR31","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/cam4.1054","volume":"6","author":"AG Ording","year":"2017","unstructured":"Ording AG, Horv\u00e1th-Puh\u00f3 E, Adelborg K, Pedersen L, Prandoni P, S\u00f8rensen HT (2017) Thromboembolic and bleeding complications during oral anticoagulation therapy in cancer patients with atrial fibrillation: a Danish nationwide population-based cohort study. Cancer Med 6:1165\u20131172. https:\/\/doi.org\/10.1002\/cam4.1054","journal-title":"Cancer Med"},{"key":"3346_CR32","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1182\/bloodadvances.2017010694","volume":"2","author":"S Shah","year":"2018","unstructured":"Shah S, Norby FL, Datta YH, Lutsey PL, MacLehose RF, Chen LY, Alonso A (2018) Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation. Blood Adv 2:200\u2013209. https:\/\/doi.org\/10.1182\/bloodadvances.2017010694","journal-title":"Blood Adv"},{"key":"3346_CR33","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.3324\/haematol.2017.164103","volume":"102","author":"I Weerdt de","year":"2017","unstructured":"de Weerdt I, Koopmans SM, Kater AP, van Gelder M (2017) Incidence and management of toxicity associated with ibrutinib and idelalisib: a practical approach. Haematologica 102:1629\u20131639. https:\/\/doi.org\/10.3324\/haematol.2017.164103","journal-title":"Haematologica"},{"key":"3346_CR34","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1080\/10428194.2017.1339874","volume":"59","author":"BC Thorp","year":"2018","unstructured":"Thorp BC, Badoux X (2018) Atrial fibrillation as a complication of ibrutinib therapy: clinical features and challenges of management. Leuk Lymphoma 59:311\u2013320. https:\/\/doi.org\/10.1080\/10428194.2017.1339874","journal-title":"Leuk Lymphoma"},{"key":"3346_CR35","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1182\/bloodadvances.2017009720","volume":"1","author":"TE Wiczer","year":"2017","unstructured":"Wiczer TE, Levine LB, Brumbaugh J, Coggins J, Zhao Q, Ruppert AS, Rogers K, McCoy A, Mousa L, Guha A, Heerema NA, Maddocks K, Christian B, Andritsos LA, Jaglowski S, Devine S, Baiocchi R, Woyach J, Jones J, Grever M, Blum KA, Byrd JC, Awan FT (2017) Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinib. Blood Adv 1:1739\u20131748","journal-title":"Blood Adv"},{"key":"3346_CR36","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.jacc.2017.06.047","volume":"70","author":"BB Navi","year":"2017","unstructured":"Navi BB, Reiner AS, Kamel H, Iadecola C, Okin PM, Elkind MSV, Panageas KS, DeAngelis LM (2017) Risk of arterial thromboembolism in patients with Cancer. J Am Coll Cardiol 70:926\u2013938. https:\/\/doi.org\/10.1016\/j.jacc.2017.06.047","journal-title":"J Am Coll Cardiol"},{"key":"3346_CR37","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1161\/STROKEAHA.112.658625","volume":"43","author":"CJ Schwarzbach","year":"2012","unstructured":"Schwarzbach CJ, Schaefer A, Ebert A, Held V, Bolognese M, Kablau M, Hennerici MG, Fatar M (2012) Stroke and cancer: the importance of cancer-associated hypercoagulation as a possible stroke etiology. Stroke 43:3029\u20133034. https:\/\/doi.org\/10.1161\/STROKEAHA.112.658625","journal-title":"Stroke"},{"key":"3346_CR38","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ana.24325","volume":"77","author":"BB Navi","year":"2015","unstructured":"Navi BB, Reiner AS, Kamel H, Iadecola C, Elkind MS, Panageas KS, DeAngelis LM (2015) Association between incident cancer and subsequent stroke. Ann Neurol 77:291\u2013300. https:\/\/doi.org\/10.1002\/ana.24325","journal-title":"Ann Neurol"},{"key":"3346_CR39","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1016\/j.amjcard.2017.08.038","volume":"120","author":"R Patell","year":"2017","unstructured":"Patell R, Gutierrez A, Rybicki L, Khorana AA (2017) Usefulness of CHADS2 and CHA2DS2-VASc scores for stroke prediction in patients with cancer and atrial fibrillation. Am J Cardiol 120:2182\u20132186. https:\/\/doi.org\/10.1016\/j.amjcard.2017.08.038","journal-title":"Am J Cardiol"},{"key":"3346_CR40","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.amjcard.2017.11.027","volume":"121","author":"A Elbadawi","year":"2018","unstructured":"Elbadawi A, Elgendy IY, Ha LD, Baig B, Saad M, Adly H, Ogunbayo GO, Olorunfemi O, Mckillop MS, Maffett SA (2018) In-hospital cerebrovascular outcomes of patients with atrial fibrillation and cancer (from the National Inpatient Sample Database). Am J Cardiol 121:590\u2013595. https:\/\/doi.org\/10.1016\/j.amjcard.2017.11.027","journal-title":"Am J Cardiol"},{"key":"3346_CR41","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1177\/2047487318759858","volume":"25","author":"M D'Souza","year":"2018","unstructured":"D'Souza M, Carlson N, Fosb\u00f8l E, Lamberts M, Smedegaard L, Nielsen D, Torp-Pedersen C, Gislason G, Schou M (2018) CHA2DS2-VASc score and risk of thromboembolism and bleeding in patients with atrial fibrillation and recent cancer. Eur J Prev Cardiol 25:651\u2013658. https:\/\/doi.org\/10.1177\/2047487318759858","journal-title":"Eur J Prev Cardiol"},{"key":"3346_CR42","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1160\/TH16-11-0895","volume":"117","author":"RM Santi","year":"2017","unstructured":"Santi RM, Ceccarelli M, Bernocco E, Monagheddu C, Evangelista A, Valeri F, Monaco F, Vitolo U, Cortelazzo S, Cabras MG, Spina M, Baldini L, Boccomini C, Chiappella A, Bari A, Luminari S, Visco C, Calabrese M, Limberti G, Levis A, Contino L, Ciccone G, Ladetto M (2017) Khorana score and histotype predicts incidence of early venous thromboembolism in non-Hodgkin lymphomas. A pooled-data analysis of 12 clinical trials of Fondazione Italiana Linfomi (FIL). Thromb Haemost (in press) 117:1615\u20131621. https:\/\/doi.org\/10.1160\/TH16-11-0895.","journal-title":"Thromb Haemost"},{"key":"3346_CR43","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1182\/blood-2010-01-258624","volume":"115","author":"V Caruso","year":"2010","unstructured":"Caruso V, Di Castelnuovo A, Meschengieser S, Lazzari MA, de Gaetano G, Storti S, Iacoviello L, Donati MB (2010) Thrombotic complications in adult patients with lymphoma: a meta-analysis of 29 independent cohorts including 18 018 patients and 1149 events. Blood 115:5322\u20135328. https:\/\/doi.org\/10.1182\/blood-2010-01-258624","journal-title":"Blood"},{"key":"3346_CR44","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jacc.2017.10.088","volume":"71","author":"BB Navi","year":"2018","unstructured":"Navi BB, Reiner AS, Kamel H, Iadecola C, Okin PM, Elkind MSV, Panageas KS, DeAngelis LM (2018) Reply: arterial thromboembolism in non-hodgkin lymphoma, as the presentation of occult cancer, and with cancer therapies. J Am Coll Cardiol 71:260\u2013262. https:\/\/doi.org\/10.1016\/j.jacc.2017.10.088","journal-title":"J Am Coll Cardiol"},{"key":"3346_CR45","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.amjcard.2016.07.049","volume":"118","author":"M Amioka","year":"2016","unstructured":"Amioka M, Sairaku A, Ochi T, Okada T, Asaoku H, Kyo T, Kihara Y (2016) Prognostic significance of new-onset atrial fibrillation in patients with non-Hodgkin's lymphoma treated with anthracyclines. Am J Cardiol 118:1386\u20131389. https:\/\/doi.org\/10.1016\/j.amjcard.2016.07.049","journal-title":"Am J Cardiol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3346-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3346-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3346-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T09:30:46Z","timestamp":1571304646000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3346-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,4]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["3346"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3346-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,4]]},"assertion":[{"value":"16 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}